The plasma fractionation facility will be built to produce daily batches of 4,000 L of plasma per day for a total of approximately 1,000,000 liters per year, for the production of Albumin and Intravenous Immunoglobulin (IVIG-SM). The plant shall be completed, validated and in trial production for the first quarter of 2017.

Read more ...
Page 1 of 2

Want to work with us?
Send Us your CV

Send Us your Corporate Profile
Company Profile